People · Operator
Named in public records as an officer, director or promoter · active 2012–2017 · Other, Manufacturing, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Chromatin, Inc. | — | Other | Series B | $61.3M | $228.4M | 2013 |
| Biosynthetic Technologies, Llc | — | Manufacturing | Series B | $52.2M | $181.0M | 2012 |
| Taxon Biosciences Inc. | — | Other Technology | Series A | $4.0M | $111.3M | 2013 |
Meghan Sharp at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Meghan Sharp on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Shapiro | 1 | 13 |
| James Kim | 1 | 10 |
| John Hamer | 1 | 7 |
| George Arida | 1 | 6 |
| Paul Deutch | 1 | 4 |
| Bernhard Mohr | 1 | 3 |
| David Woodburn | 1 | 3 |
| Matthew Ashby | 1 | 2 |
| Daphne Preuss | 1 | 2 |
| Henry Hirvela | 1 | 2 |
| Armand Lavoie | 1 | 2 |
| David Jessen | 1 | 1 |
| N/A Meghan Sharp | 1 | 1 |
| Jeff Widder | 1 | 1 |
| David Zimmerman | 1 | 1 |
| Robert Saul | 1 | 1 |
| Cathryn Taylor | 1 | 1 |
| Ducommun Steven | 1 | 1 |
| Troy Randolph | 1 | 1 |
| Jeffrey Widder | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.